<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Lianluo Smart Limited

    Lianluo Smart Limited

    Lianluo Smart Limited is a professional smart service products provider, which dev...

    Lianluo Smart Limited is a professional smart s...

    Filing Type:    PU
    Cutera, Inc.

    Cutera, Inc.

    CUTERA, Inc. was founded in 1998 and is a global provider of Face + Body laser, li...

    CUTERA, Inc. was founded in 1998 and is a globa...

    Filing Type:    PU
    Crooru Corporation

    Crooru Corporation

    crooru is an on-demand, location-based app that connects health care staff and nur...

    crooru is an on-demand, location-based app that...

    Amount Raised:    $15,000.00
    Fundraising Status:    EC
    Filing Type:    CF
    Otonomy, Inc.

    Otonomy, Inc.

    Otonomy is a biopharmaceutical company dedicated to the development of innovative ...

    Otonomy is a biopharmaceutical company dedicate...

    Filing Type:    PU
    Alpine Immune Sciences, Inc.

    Alpine Immune Sciences, Inc.

    Alpine is a development-stage specialty pharmaceutical company focused on discover...

    Alpine is a development-stage specialty pharmac...

    Filing Type:    PU
    Summit Therapeutics plc

    Summit Therapeutics plc

    Summit Therapeutics is a leader in antibiotic innovation. Our new mechanism antibi...

    Summit Therapeutics is a leader in antibiotic i...

    Filing Type:    PU
    Deciphera Pharmaceuticals, Inc.

    Deciphera Pharmaceuticals, Inc.

    Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on...

    Deciphera Pharmaceuticals is a clinical-stage b...

    Filing Type:    PU
    BeiGene, Ltd.

    BeiGene, Ltd.

    BeiGene, Ltd. (“BeiGene”) is a commercial-stage biotechnology company focused ...

    BeiGene, Ltd. (“BeiGene”) is a commercial-s...

    Filing Type:    PU
    Mustang Bio, Inc.

    Mustang Bio, Inc.

    Mustang Bio, Inc. (“Mustang”), a Fortress Biotech Company, is a clinical-stage...

    Mustang Bio, Inc. (“Mustang”), a Fortress B...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.